FTDZX
Price
$130.03
Change
-$0.76 (-0.58%)
Updated
Feb 21 closing price
Net Assets
790.98M
JNGLX
Price
$71.57
Change
-$0.51 (-0.71%)
Updated
Feb 21 closing price
Net Assets
5B
Ad is loading...

FTDZX vs JNGLX

Header iconFTDZX vs JNGLX Comparison
Open Charts FTDZX vs JNGLXBanner chart's image
Franklin Biotechnology Discovery Adv
Price$130.03
Change-$0.76 (-0.58%)
VolumeN/A
Net Assets790.98M
Janus Henderson Global Life Sciences D
Price$71.57
Change-$0.51 (-0.71%)
VolumeN/A
Net Assets5B
FTDZX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FTDZX vs. JNGLX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTDZX is a StrongBuy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 5B vs. FTDZX (791M). JNGLX pays higher dividends than FTDZX: JNGLX (0.12) vs FTDZX (0.00). FTDZX was incepted earlier than JNGLX: FTDZX (15 years) vs JNGLX (26 years). JNGLX is a more actively managed with annual turnover of: 34.00 vs. FTDZX (24.08). JNGLX has a lower initial minimum investment than FTDZX: JNGLX (2500) vs FTDZX (100000). JNGLX annual gain was more profitable for investors over the last year : -3.67 vs. FTDZX (-12.37). JNGLX return over 5 years is better than : 17.54 vs. FTDZX (-18.65).
FTDZXJNGLXFTDZX / JNGLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years26 years-
Gain YTD2.4505.42145%
Front LoadN/AN/A-
Min. Initial Investment10000025004,000%
Min. Initial Investment IRAN/AN/A-
Net Assets791M5B16%
Annual Yield % from dividends0.000.12-
Returns for 1 year-12.37-3.67337%
Returns for 3 years18.6215.97117%
Returns for 5 years-18.6517.54-106%
Returns for 10 years-29.8929.25-102%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRAX44.46-0.12
-0.27%
MFS International Growth A
DBOCX23.75-0.30
-1.25%
BNY Mellon Balanced Opportunity C
PMPRX15.37-0.29
-1.85%
Principal MidCap Value I R3
TETAX13.61-0.29
-2.09%
RBC Enterprise A
GSXPX54.04-1.36
-2.45%
Goldman Sachs Small Cp Val Insghts P